pertuzumab
Aug 13, 2024
Roche’s HER2-Positive Breast Cancer Treatment Franchise
For most of the last century, breast cancer was categorized only by its location in the body; as a result, treatment results varied significantly. Patients with metastatic HER2+ breast cancer were traditionally treated with conventional chemotherapy regimens until trastuzumab became available. In September 1998, th...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
